Trial Profile
Study of MMFS-01 in patients with cognitive impairment
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Oct 2015
Price :
$35
*
At a glance
- Drugs MMFS 01 (Primary)
- Indications Cognition disorders
- Focus Therapeutic Use
- 30 Oct 2015 New trial record
- 28 Oct 2015 Results published in Neurocentria media release.